慢性疼痛の世界市場レポート 2024

慢性疼痛の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.9%の年間複合成長率（CAGR）で1,063億1,000万米ドルに成長すると予想されます。予測期間で予想される成長は、人口の高齢化、遠隔医療の拡大、公衆衛生意識の高まり、遺伝子調査と精密医療の進歩、慢性疼痛に寄与する心理社会的ストレス要因の認識など、いくつかの要因に起因すると考えられます。予測期間の主な動向には、痛みのモニタリングと管理のためのウェアラブルデバイスの統合、痛みの教育とサポートグループの推進、総合的な疼痛管理アプローチの採用、非オピオイド疼痛管理戦略の重視、再生医療の探求などが含まれます。痛みを和らげるための薬の応用。これらの動向は集合的に、慢性疼痛管理の情勢に貢献しています。

慢性疼痛市場は、通常の治癒期間を超えて長期にわたる持続的な痛みを経験する人がかなりの割合で発生しているため、拡大しています。医薬品や医療機器を含む効果的な疼痛管理ソリューションに対する継続的な需要が、業界内のイノベーションと成長を促進しています。例えば、2023年4月の米国疾病予防管理センター（Centers for Disease Control and Prevention）のMorbidity and Mortality Weekly Report（MMWR）によると、2021年の米国成人の慢性疼痛の有病率は20.5％から21.8％で、影響の大きい慢性疼痛は6.9％から7.8％であった。この有病率は、疼痛管理ソリューションの需要増加による市場の成長を裏付けています。

社会における高齢者の割合の増加を特徴とする高齢化社会は、慢性疼痛市場の拡大に大きく貢献しています。人口の高齢化が進むにつれ、加齢に伴う症状に対処し、全体的な身体的および精神的な健康を促進するための慢性疼痛管理戦略への依存が高まっています。世界保健機関の2022年10月の予測によると、世界の60歳以上の人口は2050年までに倍増し、21億人に達すると予想されています。この傾向は、高齢化人口のニーズに応えるための慢性疼痛管理ソリューションの需要が引き続き高まり、それによって市場の成長を促進することを示唆しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の慢性疼痛市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 薬剤
• デバイス
• 世界の慢性疼痛市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 神経因性疼痛
• 関節炎の痛み
• 慢性腰痛
• がんの痛み
• 片頭痛
• 線維筋痛症
• その他の適応症
• 世界の慢性疼痛市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院
• クリニック
• 研究組織

第7章 地域および国の分析

• 世界の慢性疼痛市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の慢性疼痛市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性疼痛市場の競合情勢
• 慢性疼痛市場の企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson
  • AbbVie Inc.
  • Novartis AG
  • Sanofi SA

第31章 その他の大手および革新的な企業

• Bristol-Myers Squibb Company
• Abbott Laboratories
• Mitsubishi Chemical Group Corporation
• GlaxoSmithKline plc.
• Eli Lilly and Company
• AstraZeneca plc.
• Becton, Dickinson, and Company
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Endo International plc.
• Noven Pharmaceuticals Inc.
• Anika Therapeutics Inc.
• Collegium Pharmaceutical Inc.
• Heron Therapeutics Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Chronic pain is characterized by persistent or long-lasting discomfort that extends beyond the normal healing period following an injury or illness. It can have diverse origins, including injuries, underlying medical conditions, nerve damage, inflammation, musculoskeletal disorders, and specific diseases such as arthritis, fibromyalgia, or neuropathy.

The primary products utilized for managing chronic pain are drugs and devices. Drugs refer to substances used for diagnosing, preventing, or treating diseases or medical conditions. Commonly employed medications for chronic pain include opioids and non-steroidal anti-inflammatory drugs (NSAIDs), aimed at alleviating pain symptoms and addressing underlying causes. These drugs are utilized for various indications, including neuropathic pain, arthritis pain, chronic back pain, cancer pain, migraines, fibromyalgia, and others. End-users of these products include hospitals, clinics, and research organizations.

The chronic pain market research report is one of a series of new reports from The Business Research Company that provides chronic pain market statistics, including chronic pain industry global market size, regional shares, competitors with a chronic pain market share, detailed chronic pain market segments, market trends and opportunities, and any further data you may need to thrive in the chronic pain industry. This chronic pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic pain market size has grown strongly in recent years. It will grow from $72.13 billion in 2023 to $78.29 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the historical period can be attributed to various factors, including injuries and trauma, surgical procedures, inflammatory conditions, nerve damage, and neuropathy. Additionally, the historical growth may be influenced by the lack of effective treatments for managing chronic pain in certain cases. These factors collectively contributed to the prevalence and persistence of chronic pain during the historic period.

The chronic pain market size is expected to see strong growth in the next few years. It will grow to $106.31 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be attributed to several factors, including an aging population, the expansion of telemedicine, increased public health awareness, advancements in genetic research and precision medicine, and the recognition of psychosocial stressors contributing to chronic pain. Key trends in the forecast period include the integration of wearable devices for monitoring and managing pain, the promotion of pain education and support groups, the adoption of holistic pain management approaches, the emphasis on non-opioid pain management strategies, and the exploration of regenerative medicine applications for pain relief. These trends collectively contribute to the evolving landscape of chronic pain management.

The chronic pain market is expanding due to the substantial prevalence of individuals experiencing prolonged, persistent pain that extends beyond normal healing periods. This continuous demand for effective pain management solutions, encompassing pharmaceuticals and medical devices, fuels innovation and growth within the industry. For instance, as per the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report (MMWR) in April 2023, the prevalence of chronic pain among US adults in 2021 ranged from 20.5% to 21.8%, with high-impact chronic pain ranging from 6.9% to 7.8%. This prevalence underscores the market's growth due to increased demand for pain management solutions.

The aging demographic, characterized by a larger proportion of elderly individuals in society, contributes significantly to the expansion of the chronic pain market. As the population ages, there's an augmented reliance on chronic pain management strategies to address age-related conditions, promoting overall physical and mental well-being. According to the World Health Organization's projections from October 2022, the global population aged 60 years and older is set to double by 2050, reaching 2.1 billion. This trend suggests a continued upsurge in demand for chronic pain management solutions to cater to the needs of the aging population, thereby driving market growth.

Companies in the chronic pain market are actively concentrating on novel and user-friendly nerve stimulation devices employing electrical impulses to alleviate pain. These portable devices provide non-invasive pain management options. For instance, Abbott Laboratories, a prominent US healthcare firm, introduced Eterna in December 2022. Eterna stands as the most compact implantable and rechargeable spinal cord stimulation (SCS) system available. Utilizing Abbott's unique low-dose BurstDR stimulation, it demonstrated a 23% greater pain reduction compared to traditional waveform technologies, supported by extensive clinical evidence (1A evidence).

Major players in the chronic pain market are embracing a strategic partnership approach to introduce a shared savings program aimed at managing chronic pain effectively. This collaborative strategy involves leveraging the combined strengths and resources of involved companies. In August 2023, MOBE, a US-based digital health innovator, joined forces with Override Health, a healthcare company in the US. Their shared objective is to address chronic pain management through a program that amalgamates their respective expertise. MOBE employs healthcare data analytics for high-touch, one-to-one health coaching and medication management, while Override Health offers virtual interdisciplinary care, neuroplasticity-centered coaching, and peer support to assist individuals navigating the complexities of chronic pain.

In March 2021, the US-based digital health company Hinge Health Inc. successfully acquired Enso for an undisclosed amount. The strategic acquisition was intended to bolster Hinge Health's capabilities in delivering comprehensive digital solutions for chronic musculoskeletal conditions, particularly targeting back and joint pain. By integrating Enso's medical devices into its platform, Hinge Health sought to provide a more holistic and personalized approach to pain management, thereby solidifying its position in the digital health market. Enso, a US-based medical device company, specializes in the development of pain management devices.

Major companies operating in the chronic pain market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

North America was the largest region in the chronic pain market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic pain market consists of sales of opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antidepressants, and other analgesics that are used to manage chronic pain. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Pain Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic pain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic pain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Drug; Devices
• 2) By Indication: Neuropathic Pain; Arthritis Pain; Chronic Back Pain; Cancer Pain; Migraine; Fibromyalgia; Other Indications
• 3) By End User: Hospitals; Clinics; Research Organization
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Novartis AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Pain Market Characteristics

3. Chronic Pain Market Trends And Strategies

4. Chronic Pain Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Chronic Pain Market Size and Growth

• 5.1. Global Chronic Pain Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Chronic Pain Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Chronic Pain Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chronic Pain Market Segmentation

• 6.1. Global Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Drug
• Devices
• 6.2. Global Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Neuropathic Pain
• Arthritis Pain
• Chronic Back Pain
• Cancer Pain
• Migraine
• Fibromyalgia
• Other Indications
• 6.3. Global Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Research Organization

7. Chronic Pain Market Regional And Country Analysis

• 7.1. Global Chronic Pain Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Chronic Pain Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chronic Pain Market

• 8.1. Asia-Pacific Chronic Pain Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chronic Pain Market

• 9.1. China Chronic Pain Market Overview
• 9.2. China Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chronic Pain Market

• 10.1. India Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chronic Pain Market

• 11.1. Japan Chronic Pain Market Overview
• 11.2. Japan Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chronic Pain Market

• 12.1. Australia Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chronic Pain Market

• 13.1. Indonesia Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chronic Pain Market

• 14.1. South Korea Chronic Pain Market Overview
• 14.2. South Korea Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chronic Pain Market

• 15.1. Western Europe Chronic Pain Market Overview
• 15.2. Western Europe Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chronic Pain Market

• 16.1. UK Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chronic Pain Market

• 17.1. Germany Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chronic Pain Market

• 18.1. France Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chronic Pain Market

• 19.1. Italy Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chronic Pain Market

• 20.1. Spain Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chronic Pain Market

• 21.1. Eastern Europe Chronic Pain Market Overview
• 21.2. Eastern Europe Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chronic Pain Market

• 22.1. Russia Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chronic Pain Market

• 23.1. North America Chronic Pain Market Overview
• 23.2. North America Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chronic Pain Market

• 24.1. USA Chronic Pain Market Overview
• 24.2. USA Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chronic Pain Market

• 25.1. Canada Chronic Pain Market Overview
• 25.2. Canada Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chronic Pain Market

• 26.1. South America Chronic Pain Market Overview
• 26.2. South America Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chronic Pain Market

• 27.1. Brazil Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chronic Pain Market

• 28.1. Middle East Chronic Pain Market Overview
• 28.2. Middle East Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chronic Pain Market

• 29.1. Africa Chronic Pain Market Overview
• 29.2. Africa Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chronic Pain Market Competitive Landscape And Company Profiles

• 30.1. Chronic Pain Market Competitive Landscape
• 30.2. Chronic Pain Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Sanofi S.A.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Chronic Pain Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. Abbott Laboratories
• 31.3. Mitsubishi Chemical Group Corporation
• 31.4. GlaxoSmithKline plc.
• 31.5. Eli Lilly and Company
• 31.6. AstraZeneca plc.
• 31.7. Becton, Dickinson, and Company
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Regeneron Pharmaceuticals Inc.
• 31.10. Biogen Inc.
• 31.11. Endo International plc.
• 31.12. Noven Pharmaceuticals Inc.
• 31.13. Anika Therapeutics Inc.
• 31.14. Collegium Pharmaceutical Inc.
• 31.15. Heron Therapeutics Inc.

32. Global Chronic Pain Market Competitive Benchmarking

33. Global Chronic Pain Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chronic Pain Market

35. Chronic Pain Market Future Outlook and Potential Analysis

• 35.1 Chronic Pain Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Chronic Pain Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Chronic Pain Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer